⚠️ Under the Microscope: Max Lewinsohn and the Murky World of Stem Cell “Cell-Free” Therapies

 

⚠️ Under the Microscope: Max Lewinsohn and the Murky World of Stem Cell “Cell-Free” Therapies

By Steven Millard - Investigative Reporter | Special Report – June 2025

An expanding shadow has begun to loom over a growing sector in global regenerative medicine—one that promises revolutionary health benefits using so-called cell-free therapies. At the center of this storm stands Max Robert Lewinsohn, a UK-based entrepreneur and self-proclaimed chairman of the Wellbeing International Foundation Ltd., a company now drawing scrutiny from health authorities and consumer rights watchdogs across several jurisdictions.

🧪 The Pitch: Cell-Free “Exosome” Therapy

The therapies in question are based not on stem cells themselves, but on extracellular vesicles (EVs), sometimes marketed as “cell-free” regenerative solutions. These EVs are harvested from stem-cell cultures and are believed to carry regenerative properties via proteins and signaling molecules.

Companies like Wellbeing International Foundation Ltd. have publicly claimed to offer such therapies at elite clinics internationally—targeting chronic injury sufferers, aging individuals, and even professional athletes with promises of cellular repair, joint rejuvenation, and overall health enhancement.

Max Lewinsohn, aged 78, has been at the helm of these ventures, appearing in interviews and media as an advocate and testimonial subject. He describes personal benefits from EV therapy as early as 2010, crediting it for alleviating sports injuries and improving joint function.

But behind the glossy narrative, cracks are appearing.

🔍 Unregulated, Unproven, and Under Investigation

Despite the clinical veneer, Wellbeing International Foundation Ltd. has not registered any clinical trials in the United States, UK, or European Union—a red flag for any medical organization administering biologically active therapies. A global search of ClinicalTrials.gov, the European Medicines Agency, and the MHRA in the UK reveals no trace of approved studies, pending trials, or peer-reviewed data to support their treatment claims.

Additionally, the foundation has drawn criticism for operating in jurisdictions known for lax medical oversight—such as Bermuda—and advertising services that appear to sidestep stringent regulation by redefining stem cell therapy as “cell-free.”

This play on semantics, experts warn, is being used to market potentially risky therapies without regulatory accountability.

🏢 Lewinsohn’s Web of Interests

Max Lewinsohn’s entrepreneurial history spans several industries, from green energy to film production, and notably includes Micropower Global, a thermoelectric company now in liquidation. However, it is his leadership in Wellbeing International Foundation Ltd., and potentially affiliated partnerships with biotech ventures like Kimera Labs, that has raised concern in medical watchdog circles.

A 2025 biotech report listed Lewinsohn as chairman of a “Healthspan Consortium” alongside regenerative companies working on perinatal exosome production—further linking him to a web of unverified cellular-based therapies.

🛑 Expert Warnings

Several regulatory experts and stem-cell researchers have sounded the alarm:

“Any time a company markets injectable biologics outside of an approved clinical framework, especially in countries with poor enforcement, you’re in dangerous territory.”
— Dr. Melissa Grant, Cellular Therapeutics Oversight Network

“EV-based therapies may have promise in lab settings, but without human trials and peer-reviewed data, what’s being sold could range from ineffective to downright harmful.”
— Prof. James Morton, Institute for Biomedical Ethics

💰 Follow the Money

A number of Wellbeing International Foundation Ltd.’s public materials focus not on the science, but on investment opportunities—a classic hallmark of high-risk biotech ventures bordering on the gray area of medical finance fraud. Investors are lured with promises of groundbreaking treatments and explosive returns, even though no product has passed through Phase I clinical trials, let alone gained market approval.

This strategy, some analysts say, mirrors tactics used in past stem-cell fraud cases, where early-stage medical claims were used to inflate valuations and lure private investors before regulators shut the operation down.

⚖️ Calls for Oversight

Sources indicate that regulatory bodies in the UK and EU have received inquiries about the activities of Wellbeing International Foundation Ltd., although no formal charges have yet been filed. However, increasing interest from medical ethics councils, patient advocacy groups, and financial fraud units suggests that the pressure on Lewinsohn and his affiliated companies is mounting.

🚨The Pattern of a Cautionary Tale

While Max Lewinsohn has not been formally accused of wrongdoing, the growing concerns around unregulated biologics, unproven medical claims, and offshore biotech operations should serve as a warning. In an industry already fraught with false hope and medical exploitation, transparency, regulation, and scientific integrity must take priorityover investor excitement and promotional flair.

As governments around the world begin cracking down on pseudomedical treatments and offshore stem-cell tourism, all eyes may soon turn to Wellbeing International Foundation Ltd.—and the man at its helm.

Comments

Post a Comment

Popular posts from this blog

🌍 Global Pattern of Fraud? An Investigative Exposé

Image
The Rise and Fall of Wellbeing International Foundation Ltd: An Investigative Exposé By Steven Millard - Investigative Correspondent | June 2025 Wellbeing International Foundation Ltd , a company once promoting itself as a pioneer in cutting-edge regenerative medicine, is now at the center of a storm involving allegations of medical fraud, misrepresentation, and international regulatory scrutiny. With operations spanning Bermuda and the UK, the company’s sudden rise—and even swifter fall—offers a cautionary tale about the dangers of unregulated medical therapies and unchecked health claims. https://www.thetruthaboutwellbeingint.org/ 💼  The Promise of “Cell-Free Therapy” Founded in 2015 and registered in Bermuda,  Wellbeing International Foundation Ltd  marketed itself as a leader in “cell-free therapy,” a term used to describe an alleged medical process in which cell secretions from a patient’s own body are extracted, modified, and reinfused to treat a range of condition...
Read more

Steven Millard: From Victim to Watchdog

Image
  Profile Feature | Behind the Bylines – Health & Ethics Magazine Steven Millard: From Victim to Watchdog One Father’s Journey from Medical Desperation to Investigative Journalism By Editorial Staff For decades,  Steven Millard  was a name known only to the bylines of local papers and online outlets. A lifelong journalist who never needed the spotlight, Millard dedicated his post-high school years to writing, reporting, and telling the stories that mattered. But in 2022, the story that would change his life forever wasn’t one he was chasing—it was one he was living. Steven’s son, born with a rare chronic illness, became the focus of his entire world. Like any devoted father, Millard spent years chasing answers, seeking out top specialists, miracle clinics, and experimental treatments across Europe and beyond. And when traditional medicine ran out of options, he did what many desperate families do: he put his faith—and his finances—into hope. That hope came in the form...
Read more